Welcome to LookChem.com Sign In|Join Free
  • or
8-amino-7-chloro[1,2,4]triazolo[4,3-c]pyrimidin-3(2H)-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

15206-33-4

Post Buying Request

15206-33-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

15206-33-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 15206-33-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,2,0 and 6 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 15206-33:
(7*1)+(6*5)+(5*2)+(4*0)+(3*6)+(2*3)+(1*3)=74
74 % 10 = 4
So 15206-33-4 is a valid CAS Registry Number.

15206-33-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-Chloro-1,2,3-benzotriazin-4-ol

1.2 Other means of identification

Product number -
Other names 7-Chlor-1,2,3-benzotriazin-4-on

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:15206-33-4 SDS

15206-33-4Downstream Products

15206-33-4Relevant academic research and scientific papers

Triazolopyrimidine cannabinoid receptor 1 antagonists

-

Page/Page column 22-23, (2010/11/25)

The present application describes compounds according to both Formulas I and II, pharmaceutical compositions comprising at least one compound according to either Formula I or II and optionally one or more additional therapeutic agents, and methods of treatment using the compounds according to Formulas I and II both alone and in combination with one or more additional therapeutic agents. The compounds have the following general formulas: including all prodrugs, solvates, pharmaceutically acceptable salts and stereoisomers, wherein R1, R2, R3, R4 and R5 are described herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 15206-33-4